Free Trial

Hims & Hers Health (HIMS) Competitors

Hims & Hers Health logo
$49.94 +0.53 (+1.07%)
As of 03:58 PM Eastern

HIMS vs. NTRA, GH, OPCH, RDNT, BTSG, SHC, CON, PRVA, SGRY, and VCYT

Should you be buying Hims & Hers Health stock or one of its competitors? The main competitors of Hims & Hers Health include Natera (NTRA), Guardant Health (GH), Option Care Health (OPCH), RadNet (RDNT), BrightSpring Health Services (BTSG), Sotera Health (SHC), Concentra Group Holdings Parent (CON), Privia Health Group (PRVA), Surgery Partners (SGRY), and Veracyte (VCYT). These companies are all part of the "healthcare" industry.

Hims & Hers Health vs. Its Competitors

Hims & Hers Health (NYSE:HIMS) and Natera (NASDAQ:NTRA) are both large-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their analyst recommendations, dividends, valuation, risk, earnings, profitability, media sentiment and institutional ownership.

In the previous week, Hims & Hers Health had 87 more articles in the media than Natera. MarketBeat recorded 104 mentions for Hims & Hers Health and 17 mentions for Natera. Natera's average media sentiment score of 1.31 beat Hims & Hers Health's score of 0.10 indicating that Natera is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Hims & Hers Health
15 Very Positive mention(s)
11 Positive mention(s)
66 Neutral mention(s)
6 Negative mention(s)
5 Very Negative mention(s)
Neutral
Natera
12 Very Positive mention(s)
2 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Hims & Hers Health has a beta of 2.09, meaning that its share price is 109% more volatile than the S&P 500. Comparatively, Natera has a beta of 1.74, meaning that its share price is 74% more volatile than the S&P 500.

Hims & Hers Health presently has a consensus target price of $39.58, suggesting a potential downside of 20.74%. Natera has a consensus target price of $184.63, suggesting a potential upside of 9.28%. Given Natera's stronger consensus rating and higher possible upside, analysts clearly believe Natera is more favorable than Hims & Hers Health.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Hims & Hers Health
3 Sell rating(s)
8 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
1.92
Natera
0 Sell rating(s)
0 Hold rating(s)
15 Buy rating(s)
0 Strong Buy rating(s)
3.00

Hims & Hers Health has higher earnings, but lower revenue than Natera. Natera is trading at a lower price-to-earnings ratio than Hims & Hers Health, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Hims & Hers Health$1.48B7.57$126.04M$0.6972.38
Natera$1.70B13.59-$190.43M-$1.47-114.93

63.5% of Hims & Hers Health shares are owned by institutional investors. Comparatively, 99.9% of Natera shares are owned by institutional investors. 17.7% of Hims & Hers Health shares are owned by company insiders. Comparatively, 7.6% of Natera shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Hims & Hers Health has a net margin of 9.24% compared to Natera's net margin of -10.36%. Hims & Hers Health's return on equity of 22.75% beat Natera's return on equity.

Company Net Margins Return on Equity Return on Assets
Hims & Hers Health9.24% 22.75% 15.51%
Natera -10.36%-18.29%-11.68%

Summary

Hims & Hers Health beats Natera on 9 of the 16 factors compared between the two stocks.

Get Hims & Hers Health News Delivered to You Automatically

Sign up to receive the latest news and ratings for HIMS and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding HIMS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

HIMS vs. The Competition

MetricHims & Hers HealthMEDICAL INFO SYS IndustryMedical SectorNYSE Exchange
Market Cap$11.18B$2.08B$5.45B$20.31B
Dividend YieldN/AN/A5.36%3.79%
P/E Ratio72.3839.1726.5127.50
Price / Sales7.5715.68404.9138.39
Price / Cash140.3056.2225.8817.85
Price / Book23.129.087.934.53
Net Income$126.04M-$63.71M$3.15B$985.09M
7 Day Performance18.65%2.77%2.27%1.67%
1 Month Performance-11.98%3.13%4.50%4.02%
1 Year Performance147.35%6.33%32.32%12.10%

Hims & Hers Health Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
HIMS
Hims & Hers Health
2.0875 of 5 stars
$49.94
+1.1%
$39.58
-20.7%
+144.8%$11.18B$1.48B72.381,637Trending News
Gap Up
NTRA
Natera
1.341 of 5 stars
$171.14
-0.4%
$184.63
+7.9%
+55.1%$23.39B$1.70B-116.504,434Positive News
GH
Guardant Health
3.4422 of 5 stars
$49.25
+0.2%
$53.76
+9.2%
+76.1%$6.10B$774.00M-14.532,021
OPCH
Option Care Health
3.5406 of 5 stars
$31.03
-1.6%
$35.50
+14.4%
+16.4%$5.09B$5.00B25.068,088Positive News
RDNT
RadNet
3.6394 of 5 stars
$55.14
-0.2%
$69.60
+26.2%
-3.1%$4.14B$1.83B-128.2011,021Positive News
Analyst Downgrade
BTSG
BrightSpring Health Services
0.9336 of 5 stars
$22.62
+1.6%
$24.90
+10.1%
+107.2%$3.98B$11.27B80.8235,000
SHC
Sotera Health
3.0133 of 5 stars
$11.10
-2.5%
$15.80
+42.3%
-4.6%$3.15B$1.10B138.833,000Analyst Upgrade
CON
Concentra Group Holdings Parent
2.9658 of 5 stars
$20.84
+0.5%
$28.50
+36.8%
N/A$2.68B$1.90B15.6011,250
PRVA
Privia Health Group
3.5153 of 5 stars
$21.88
+0.1%
$27.77
+26.9%
+26.6%$2.67B$1.74B182.521,140
SGRY
Surgery Partners
2.3024 of 5 stars
$19.91
+3.2%
$33.56
+68.5%
-7.7%$2.55B$3.11B-13.0215,000
VCYT
Veracyte
3.465 of 5 stars
$26.57
+0.7%
$40.90
+53.9%
+26.3%$2.08B$445.76M64.72790Analyst Downgrade

Related Companies and Tools


This page (NYSE:HIMS) was last updated on 6/30/2025 by MarketBeat.com Staff
From Our Partners